SPOTLIGHT -
Commentary
Slideshow
Author(s):
Here are 10 things to consider when treating a patient with mood disorders.
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
History, Physiology, and Pharmacology of Incretins
Here's to a Psychedelic Revolution
ALTO-203 Fails to Primary Efficacy Endpoint in Phase 2 Major Depressive Disorder Trial
Blue Light Blockers: A Behavior Therapy for Mania
COMP360 Psilocybin for Treatment-Resistant Depression: Positive Phase 3 Efficacy Data
NRx Pharmaceuticals Applies for FDA National Priority Voucher for Intravenous Ketamine (NRX-100)